SAROJA PHARMA INDUSTRIES INDIA
Sector : Pharmaceuticals and health care | Smallcap | NSE
Here's the live share price of Saroja Pharma Industries India along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0₹ 0
As on Oct 30, 2025, 3:42 PM IST
Saroja Pharma Industries India Price Performance
Today's LowToday's High
₹0.00₹0.00
₹43.15
52 Weeks' Low52 Weeks' High
₹34.00₹61.95
₹43.15
Open Price
₹0.00
Prev. Close
₹43.15
Over the last 5 years, the share price of Saroja Pharma Industries India has declined 8.76% CAGR. Over the past year, the corresponding return has been -21.55%.
Saroja Pharma Industries India’s current P/E of 24.38x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Saroja Pharma Industries India Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Saroja Pharma Industries India | 1.05 | 0.82 | 19.86 | 8.83 | -21.55 | -14.17 | -8.76 |
| Sun Pharmaceutical Industries | 0.26 | 4.11 | -0.19 | -6.89 | -7.87 | 18.76 | 29.61 |
| Divi's Laboratories | 0.94 | 16.55 | 0.90 | 9.03 | 12.99 | 22.63 | 16.19 |
| Cipla | -2.80 | 1.79 | -0.93 | 0.95 | -0.75 | 9.68 | 15.34 |
| Torrent Pharmaceuticals | 0.59 | 0.99 | -3.73 | 10.67 | 12.48 | 29.73 | 22.93 |
| Mankind Pharma | 0.58 | 0.29 | -4.70 | 2.55 | -8.28 | 19.82 | 11.46 |
| Dr. Reddy's Laboratories | -6.34 | -3.41 | -5.36 | 1.63 | -5.65 | 10.68 | 4.22 |
| Zydus Lifesciences | -1.87 | -0.50 | 1.69 | 11.35 | -1.51 | 31.53 | 18.75 |
| Lupin | 0.76 | -1.79 | 0.87 | -5.41 | -11.03 | 40.67 | 16.43 |
| Alkem Laboratories | -0.36 | 1.20 | 9.82 | 8.85 | -4.40 | 20.53 | 15.97 |
| Aurobindo Pharma | 1.61 | 1.52 | -3.27 | -9.03 | -21.05 | 27.01 | 7.37 |
| Abbott India | -1.10 | -0.97 | -13.97 | -3.66 | 2.14 | 15.43 | 14.11 |
| Glenmark Pharmaceuticals | 3.52 | -3.90 | -11.78 | 36.93 | 11.11 | 66.96 | 31.72 |
| Laurus Labs | 4.74 | 11.28 | 10.98 | 56.37 | 97.53 | 28.76 | 24.89 |
| Biocon | 4.76 | 8.70 | -3.78 | 18.09 | 19.14 | 11.75 | -1.38 |
| GlaxoSmithKline Pharmaceuticals | -4.95 | -2.80 | -17.10 | -8.10 | -3.34 | 23.93 | 12.35 |
| Anthem Biosciences | -0.36 | -6.95 | -5.51 | -1.78 | -1.78 | -0.60 | -0.36 |
| Ipca Laboratories | 1.59 | -2.89 | -12.55 | -6.48 | -18.88 | 12.51 | 2.19 |
| Gland Pharma | -1.83 | -3.83 | -7.70 | 35.79 | 15.43 | 2.22 | 0.93 |
| Ajanta Pharma | 2.24 | 2.94 | -10.28 | -4.51 | -19.45 | 23.99 | 18.67 |
Over the last one year, Saroja Pharma Industries India has declined 21.55% compared to peers like Sun Pharmaceutical Industries (-7.87%), Divi's Laboratories (12.99%), Cipla (-0.75%). From a 5 year perspective, Saroja Pharma Industries India has underperformed peers relative to Sun Pharmaceutical Industries (29.61%) and Divi's Laboratories (16.19%).
Saroja Pharma Industries India Financials
Saroja Pharma Industries India Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 44.88 | 43.91 |
| 10 | 45.07 | 44.66 |
| 20 | 46.15 | 45.29 |
| 50 | 43.78 | 44.93 |
| 100 | 43.79 | 45.39 |
| 200 | 48.1 | 47.2 |
Saroja Pharma Industries India Share Holding Pattern
In the latest quarter, Saroja Pharma Industries India remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 26.99% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Saroja Pharma Industries India Corporate Actions
There's no recent Announcement information to show for the company. You may visit the Saroja Pharma Industries India fact sheet for more information
About Saroja Pharma Industries India
Saroja Pharma Industries India Ltd. is a Public Limited Listed company incorporated on 14/01/2019 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is U24110MH2019PLC319508 and registration number is 319508. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 40.67 Cr. and Equity Capital is Rs. 4.02 Cr. for the Year ended 31/03/2024.
- IndustryPharmaceuticals
- Address305, Kailash Tower, Shiv Shristi Complex, Mumbai Maharashtra 400080
- Contact
Management
- Mr. Biju Gopinathan NairChairman & Managing Director
- Mr. Manish Dasharath KambleWhole Time Director
- Mr. Pulinattu NandakumarNon Executive Director
- Mr. Abhishek AgrawalInd. Non-Executive Director
- Ms. Pinky KatarukaInd. Non-Executive Director
- Ms. Sonal JainInd. Non-Executive Director
FAQs on Saroja Pharma Industries India Share Price
What is the share price of Saroja Pharma Industries India?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Saroja Pharma Industries India is ₹43.15 as on Oct 30, 2025.
What kind of stock is Saroja Pharma Industries India?
The Saroja Pharma Industries India is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the NSE.
What is the Market Cap of Saroja Pharma Industries India?
The market cap of Saroja Pharma Industries India is ₹17.35 Cr as on Oct 30, 2025.
What are today's High and Low prices of Saroja Pharma Industries India?
Today’s highest and lowest price of Saroja Pharma Industries India are ₹0.00 and ₹0.00.
What are the 52 Week High and 52 Week Low of Saroja Pharma Industries India?
The 52-week high/low is the highest and lowest price at which Saroja Pharma Industries India stock has traded in the past 52-week or nearly a year. The 52-week high of Saroja Pharma Industries India is ₹61.95 and 52-week low of Saroja Pharma Industries India is ₹34.00 as on Oct 30, 2025.
How has the Saroja Pharma Industries India performed historically in terms of returns?
The Saroja Pharma Industries India has shown returns of 0.0% over the past day, -4.11% for the past month, 20.53% over 3 months, -21.55% over 1 year, -14.17% across 3 years, and -8.76% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Saroja Pharma Industries India?
P/E ratio of and PB ratio of Saroja Pharma Industries India are 24.38 and 1.18 on Oct 30, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse